Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis

Nicolino Ruperto, Angelo Ravelli, Kevin J. Murray, Daniel J. Lovell, Boel Andersson-Gare, Brian M. Feldman, Stella Garay, Wietse Kuis, Claudio Machado, Lauren Pachman, Anne Marie Prieur, Lisa G. Rider, Earl Silverman, Elena Tsitsami, Pat Woo, Edward H. Giannini, Alberto Martini, Sang Cheol Bae, Z. Balogh, Ruben Burgos-Vargas & 25 others Carmen De Cunto, Jaime De Inocencio, Pavla Dolezalova, Miroslav Harjacek, Philip Hashkes, Michael Hofer, Visa Honkanen, Christian Huemer, Hans Iko Huppertz, Rik Joos, Florence Kanakoudi, Vibke Lilleby, Jose Melo-Gomes, Dimitrina Mihaylova, Susan Nielsen, Irina Nikishina, Huri Ozdogan, Kharaman Pagava, Anne M. Reed, Robert Rennebohm, Anna Maria Romicka, Madeleine Rooney, Ingrida Rumba, Gordana Susic, Richard Vesely

Research output: Contribution to journalArticle

167 Citations (Scopus)

Abstract

Objective. To identify preliminary core sets of outcome variables for disease activity and damage assessment in juvenile systemic lupus erythematosus (JSLE) and juvenile dermatomyositis (JDM). Methods. Two questionnaire surveys were mailed to 267 physicians from 46 different countries asking each member to select and rank the response variables used when assessing clinical response in patients with JSLE or JDM. Next, 40 paediatric rheumatologists from 34 countries met and, using the nominal group technique, selected the domains to be included in the disease activity and damage core sets for JSLE and JDM. Results. A total of 41 response variables for JSLE and 37 response variables for JDM were selected and ranked through the questionnaire surveys. In the consensus conference, domains selected for both JSLE and JDM activity or damage core sets included the physician and parent/patient subjective assessments and a global score tool. Domains specific for JSLE activity were the immunological tests and the kidney function parameters. Concerning JDM, functional ability and muscle strength assessments were indicated for both activity and damage core sets, whereas serum muscle enzymes were included only in the activity core set. A specific paediatric domain called 'growth and development' was introduced in the disease damage core set for both diseases and the evaluation of health-related quality of life was advised in order to capture the influence of the disease on the patient lifestyle. Conclusions. We developed preliminary core sets of measures for disease activity and damage assessment in JSLE and JDM. The prospective validation of the core sets is in progress.

Original languageEnglish
Pages (from-to)1452-1459
Number of pages8
JournalRheumatology
Volume42
Issue number12
DOIs
Publication statusPublished - Dec 2003

Fingerprint

Systemic Lupus Erythematosus
Pediatrics
Physicians
Immunologic Tests
Aptitude
Muscle Strength
Juvenile dermatomyositis
Growth and Development
Life Style
Consensus
Quality of Life
Kidney
Muscles
Enzymes
Serum

Keywords

  • Consensus
  • Core set
  • Disease activity assessment
  • Disease damage assessment
  • Juvenile dermatomyositis
  • Juvenile systemic lupus erythematosus

ASJC Scopus subject areas

  • Neuroscience(all)
  • Rheumatology

Cite this

Ruperto, N., Ravelli, A., Murray, K. J., Lovell, D. J., Andersson-Gare, B., Feldman, B. M., ... Vesely, R. (2003). Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology, 42(12), 1452-1459. https://doi.org/10.1093/rheumatology/keg403

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. / Ruperto, Nicolino; Ravelli, Angelo; Murray, Kevin J.; Lovell, Daniel J.; Andersson-Gare, Boel; Feldman, Brian M.; Garay, Stella; Kuis, Wietse; Machado, Claudio; Pachman, Lauren; Prieur, Anne Marie; Rider, Lisa G.; Silverman, Earl; Tsitsami, Elena; Woo, Pat; Giannini, Edward H.; Martini, Alberto; Bae, Sang Cheol; Balogh, Z.; Burgos-Vargas, Ruben; De Cunto, Carmen; De Inocencio, Jaime; Dolezalova, Pavla; Harjacek, Miroslav; Hashkes, Philip; Hofer, Michael; Honkanen, Visa; Huemer, Christian; Huppertz, Hans Iko; Joos, Rik; Kanakoudi, Florence; Lilleby, Vibke; Melo-Gomes, Jose; Mihaylova, Dimitrina; Nielsen, Susan; Nikishina, Irina; Ozdogan, Huri; Pagava, Kharaman; Reed, Anne M.; Rennebohm, Robert; Romicka, Anna Maria; Rooney, Madeleine; Rumba, Ingrida; Susic, Gordana; Vesely, Richard.

In: Rheumatology, Vol. 42, No. 12, 12.2003, p. 1452-1459.

Research output: Contribution to journalArticle

Ruperto, N, Ravelli, A, Murray, KJ, Lovell, DJ, Andersson-Gare, B, Feldman, BM, Garay, S, Kuis, W, Machado, C, Pachman, L, Prieur, AM, Rider, LG, Silverman, E, Tsitsami, E, Woo, P, Giannini, EH, Martini, A, Bae, SC, Balogh, Z, Burgos-Vargas, R, De Cunto, C, De Inocencio, J, Dolezalova, P, Harjacek, M, Hashkes, P, Hofer, M, Honkanen, V, Huemer, C, Huppertz, HI, Joos, R, Kanakoudi, F, Lilleby, V, Melo-Gomes, J, Mihaylova, D, Nielsen, S, Nikishina, I, Ozdogan, H, Pagava, K, Reed, AM, Rennebohm, R, Romicka, AM, Rooney, M, Rumba, I, Susic, G & Vesely, R 2003, 'Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis', Rheumatology, vol. 42, no. 12, pp. 1452-1459. https://doi.org/10.1093/rheumatology/keg403
Ruperto, Nicolino ; Ravelli, Angelo ; Murray, Kevin J. ; Lovell, Daniel J. ; Andersson-Gare, Boel ; Feldman, Brian M. ; Garay, Stella ; Kuis, Wietse ; Machado, Claudio ; Pachman, Lauren ; Prieur, Anne Marie ; Rider, Lisa G. ; Silverman, Earl ; Tsitsami, Elena ; Woo, Pat ; Giannini, Edward H. ; Martini, Alberto ; Bae, Sang Cheol ; Balogh, Z. ; Burgos-Vargas, Ruben ; De Cunto, Carmen ; De Inocencio, Jaime ; Dolezalova, Pavla ; Harjacek, Miroslav ; Hashkes, Philip ; Hofer, Michael ; Honkanen, Visa ; Huemer, Christian ; Huppertz, Hans Iko ; Joos, Rik ; Kanakoudi, Florence ; Lilleby, Vibke ; Melo-Gomes, Jose ; Mihaylova, Dimitrina ; Nielsen, Susan ; Nikishina, Irina ; Ozdogan, Huri ; Pagava, Kharaman ; Reed, Anne M. ; Rennebohm, Robert ; Romicka, Anna Maria ; Rooney, Madeleine ; Rumba, Ingrida ; Susic, Gordana ; Vesely, Richard. / Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. In: Rheumatology. 2003 ; Vol. 42, No. 12. pp. 1452-1459.
@article{f47cf40a52b04fa8b32cb3b175267528,
title = "Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis",
abstract = "Objective. To identify preliminary core sets of outcome variables for disease activity and damage assessment in juvenile systemic lupus erythematosus (JSLE) and juvenile dermatomyositis (JDM). Methods. Two questionnaire surveys were mailed to 267 physicians from 46 different countries asking each member to select and rank the response variables used when assessing clinical response in patients with JSLE or JDM. Next, 40 paediatric rheumatologists from 34 countries met and, using the nominal group technique, selected the domains to be included in the disease activity and damage core sets for JSLE and JDM. Results. A total of 41 response variables for JSLE and 37 response variables for JDM were selected and ranked through the questionnaire surveys. In the consensus conference, domains selected for both JSLE and JDM activity or damage core sets included the physician and parent/patient subjective assessments and a global score tool. Domains specific for JSLE activity were the immunological tests and the kidney function parameters. Concerning JDM, functional ability and muscle strength assessments were indicated for both activity and damage core sets, whereas serum muscle enzymes were included only in the activity core set. A specific paediatric domain called 'growth and development' was introduced in the disease damage core set for both diseases and the evaluation of health-related quality of life was advised in order to capture the influence of the disease on the patient lifestyle. Conclusions. We developed preliminary core sets of measures for disease activity and damage assessment in JSLE and JDM. The prospective validation of the core sets is in progress.",
keywords = "Consensus, Core set, Disease activity assessment, Disease damage assessment, Juvenile dermatomyositis, Juvenile systemic lupus erythematosus",
author = "Nicolino Ruperto and Angelo Ravelli and Murray, {Kevin J.} and Lovell, {Daniel J.} and Boel Andersson-Gare and Feldman, {Brian M.} and Stella Garay and Wietse Kuis and Claudio Machado and Lauren Pachman and Prieur, {Anne Marie} and Rider, {Lisa G.} and Earl Silverman and Elena Tsitsami and Pat Woo and Giannini, {Edward H.} and Alberto Martini and Bae, {Sang Cheol} and Z. Balogh and Ruben Burgos-Vargas and {De Cunto}, Carmen and {De Inocencio}, Jaime and Pavla Dolezalova and Miroslav Harjacek and Philip Hashkes and Michael Hofer and Visa Honkanen and Christian Huemer and Huppertz, {Hans Iko} and Rik Joos and Florence Kanakoudi and Vibke Lilleby and Jose Melo-Gomes and Dimitrina Mihaylova and Susan Nielsen and Irina Nikishina and Huri Ozdogan and Kharaman Pagava and Reed, {Anne M.} and Robert Rennebohm and Romicka, {Anna Maria} and Madeleine Rooney and Ingrida Rumba and Gordana Susic and Richard Vesely",
year = "2003",
month = "12",
doi = "10.1093/rheumatology/keg403",
language = "English",
volume = "42",
pages = "1452--1459",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis

AU - Ruperto, Nicolino

AU - Ravelli, Angelo

AU - Murray, Kevin J.

AU - Lovell, Daniel J.

AU - Andersson-Gare, Boel

AU - Feldman, Brian M.

AU - Garay, Stella

AU - Kuis, Wietse

AU - Machado, Claudio

AU - Pachman, Lauren

AU - Prieur, Anne Marie

AU - Rider, Lisa G.

AU - Silverman, Earl

AU - Tsitsami, Elena

AU - Woo, Pat

AU - Giannini, Edward H.

AU - Martini, Alberto

AU - Bae, Sang Cheol

AU - Balogh, Z.

AU - Burgos-Vargas, Ruben

AU - De Cunto, Carmen

AU - De Inocencio, Jaime

AU - Dolezalova, Pavla

AU - Harjacek, Miroslav

AU - Hashkes, Philip

AU - Hofer, Michael

AU - Honkanen, Visa

AU - Huemer, Christian

AU - Huppertz, Hans Iko

AU - Joos, Rik

AU - Kanakoudi, Florence

AU - Lilleby, Vibke

AU - Melo-Gomes, Jose

AU - Mihaylova, Dimitrina

AU - Nielsen, Susan

AU - Nikishina, Irina

AU - Ozdogan, Huri

AU - Pagava, Kharaman

AU - Reed, Anne M.

AU - Rennebohm, Robert

AU - Romicka, Anna Maria

AU - Rooney, Madeleine

AU - Rumba, Ingrida

AU - Susic, Gordana

AU - Vesely, Richard

PY - 2003/12

Y1 - 2003/12

N2 - Objective. To identify preliminary core sets of outcome variables for disease activity and damage assessment in juvenile systemic lupus erythematosus (JSLE) and juvenile dermatomyositis (JDM). Methods. Two questionnaire surveys were mailed to 267 physicians from 46 different countries asking each member to select and rank the response variables used when assessing clinical response in patients with JSLE or JDM. Next, 40 paediatric rheumatologists from 34 countries met and, using the nominal group technique, selected the domains to be included in the disease activity and damage core sets for JSLE and JDM. Results. A total of 41 response variables for JSLE and 37 response variables for JDM were selected and ranked through the questionnaire surveys. In the consensus conference, domains selected for both JSLE and JDM activity or damage core sets included the physician and parent/patient subjective assessments and a global score tool. Domains specific for JSLE activity were the immunological tests and the kidney function parameters. Concerning JDM, functional ability and muscle strength assessments were indicated for both activity and damage core sets, whereas serum muscle enzymes were included only in the activity core set. A specific paediatric domain called 'growth and development' was introduced in the disease damage core set for both diseases and the evaluation of health-related quality of life was advised in order to capture the influence of the disease on the patient lifestyle. Conclusions. We developed preliminary core sets of measures for disease activity and damage assessment in JSLE and JDM. The prospective validation of the core sets is in progress.

AB - Objective. To identify preliminary core sets of outcome variables for disease activity and damage assessment in juvenile systemic lupus erythematosus (JSLE) and juvenile dermatomyositis (JDM). Methods. Two questionnaire surveys were mailed to 267 physicians from 46 different countries asking each member to select and rank the response variables used when assessing clinical response in patients with JSLE or JDM. Next, 40 paediatric rheumatologists from 34 countries met and, using the nominal group technique, selected the domains to be included in the disease activity and damage core sets for JSLE and JDM. Results. A total of 41 response variables for JSLE and 37 response variables for JDM were selected and ranked through the questionnaire surveys. In the consensus conference, domains selected for both JSLE and JDM activity or damage core sets included the physician and parent/patient subjective assessments and a global score tool. Domains specific for JSLE activity were the immunological tests and the kidney function parameters. Concerning JDM, functional ability and muscle strength assessments were indicated for both activity and damage core sets, whereas serum muscle enzymes were included only in the activity core set. A specific paediatric domain called 'growth and development' was introduced in the disease damage core set for both diseases and the evaluation of health-related quality of life was advised in order to capture the influence of the disease on the patient lifestyle. Conclusions. We developed preliminary core sets of measures for disease activity and damage assessment in JSLE and JDM. The prospective validation of the core sets is in progress.

KW - Consensus

KW - Core set

KW - Disease activity assessment

KW - Disease damage assessment

KW - Juvenile dermatomyositis

KW - Juvenile systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=3142718093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142718093&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/keg403

DO - 10.1093/rheumatology/keg403

M3 - Article

VL - 42

SP - 1452

EP - 1459

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 12

ER -